Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala

Publication | Closed Access

DOI

100

Citations

References

2013

Year

R.H. Behrens, Jakob P. Cramer, Tomáš Jelı́nek, Hilary Shaw, Frank von Sonnenburg, Darren Wilbraham, Thomas Weinke, David Bell, Edwin J. Asturias, Hermann L Enkerlin Pauwells,

The Lancet Infectious Diseases

VaccinationVaccine SafetyVaccine ResearchPatch VaccineEscherichia ColiVaccine EfficacyInfection ControlPublic HealthMedicineHeat-labile ToxinTraveler Diarrhea